Cardiff Park Advisors’s VanEck Biotech ETF BBH Stock Holding History

Cardiff Park Advisors’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.58K	Hold	35	–	–	﹤0.01%	362
2025 Q4	$6.62K	Hold	35	–	–	﹤0.01%	341
2025 Q3	$5.8K	Hold	35	–	–	﹤0.01%	372
2025 Q2	$5.37K	Hold	35	–	–	﹤0.01%	346
2025 Q1	$5.51K	Hold	35	–	–	﹤0.01%	342
2024 Q4	$5.49K	Hold	35	–	–	﹤0.01%	333
2024 Q3	$6.21K	Hold	35	–	–	﹤0.01%	332
2024 Q2	$5.89K	Hold	35	–	–	﹤0.01%	325
2024 Q1	$5.82K	Hold	35	–	–	﹤0.01%	342
2023 Q4	$5.79K	Buy	+35	New	+$5.39K	﹤0.01%	321
2022 Q4	–	Sell	-35	Closed	-$5K	–	312
2022 Q3	$5K	Buy	+35	New	+$5.29K	﹤0.01%	310

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Cardiff Park Advisors's BBH Position: Q1 2026 in Review

Cardiff Park Advisors held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 35 shares worth $6.58K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Cardiff Park Advisors first reported a position in BBH in Q3 2022 and has held it in 11 quarters since. The position peaked at $6.62K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Cardiff Park Advisors held 35 shares of VanEck Biotech ETF worth $6.58K as of Q1 2026.
Cardiff Park Advisors left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up ﹤0.01% of Cardiff Park Advisors's portfolio in Q1 2026, its #362 holding.
Cardiff Park Advisors first reported a position in VanEck Biotech ETF in Q3 2022 and has held it in 11 quarters since.
Cardiff Park Advisors's VanEck Biotech ETF position peaked at $6.62K in Q4 2025.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.